Obesity Trial, Recruiting NCT04997473 Sponsor: University of California, Los Angeles Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04997473
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 13 and 30 years old (inclusive)
  • You have had a stem cell transplant (any type) and it has been at least 100 days since your transplant at the time of your first study visit
  • You are male or female
  • Your BMI (a measure of body weight relative to height) is at or above the 85th percentile for your age and gender, which is considered in the overweight or obese range
  • You are able to read English, as the app used in this study is only available in English

Who may not be able to join:

  • You are younger than 13 or older than 30 years old
  • It has been fewer than 100 days since your stem cell transplant at the time of your first study visit (though you may become eligible at a later visit if it falls within the enrollment period)
  • Your BMI does not fall into the overweight or obese category for your age and gender
  • If your ability to participate is significantly affected by a health condition, a decision will be made individually on a case-by-case basis (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Theodore B Moore, MD, UCLA Health

Phone: 3102670425

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 August 2021
Est. completion
9 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

BMI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov